| Date Filed | Type | Description |
| 04/27/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/27/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
| 04/16/2018 |
8-K
| Quarterly results |
| 04/13/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 04/12/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/12/2018 |
RW
| Form RW - Registration Withdrawal Request: |
| 04/12/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/03/2018 |
8-K
| Other Events |
| 03/29/2018 |
8-K
| Other Events |
| 03/26/2018 |
GN
| Report: Developing Opportunities within AllianceBernstein Holding, Deutsche Bank Aktiengesellschaft, Syros Pharmaceuticals, Ply Gem, Ensco plc, and Berkshire Hills — Future Expectations, Projections Moving into 2018 |
| 03/23/2018 |
DEFM14C
| Form DEFM14C - Definitive information statement relating to merger or acquisition: |
| 03/12/2018 |
GN
| LAWSUIT ALERT - Andrews & Springer LLC Announces That A Class Action Has Been Filed Against Ply Gem Holdings, Inc. - PGEM |
| 03/12/2018 |
8-K
| Other Events |
| 03/05/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/05/2018 |
8-K
| Quarterly results |
| 03/05/2018 |
BW
| Ply Gem Reports Fourth Quarter 2017 Results |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Robinette Gary E reports a 1.7% stake in PLY GEM HOLDINGS, INC. |
| 02/01/2018 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 01/31/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/24/2018 |
GN
| Analysis: Positioning to Benefit within Ferroglobe, Corbus Pharmaceuticals, Meritage, Dicerna Pharmaceuticals, Castle Brands, and Ply Gem — Research Highlights Growth, Revenue, and Consolidated Results |
| 11/06/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
| 11/06/2017 |
8-K
| Quarterly results |
| 11/06/2017 |
BW
| Ply Gem Reports Third Quarter 2017 Results |
| 09/27/2017 |
BW
| Ply Gem Holdings, Inc. to Announce Third Quarter 2017 Results |
| 08/07/2017 |
10-Q
| Quarterly Report for the period ended July 1, 2017 |
| 08/07/2017 |
8-K
| Quarterly results |
| 07/13/2017 |
BW
| Ply Gem Holdings, Inc. to Announce Second Quarter 2017 Results |
| 05/18/2017 |
8-K
| Form 8-K - Current report |
| 05/08/2017 |
10-Q
| Quarterly Report for the period ended April 1, 2017 |
| 05/08/2017 |
8-K
| Form 8-K - Current report |
| 05/08/2017 |
BW
| Ply Gem Reports First Quarter 2017 Results |
| 04/10/2017 |
BW
| Ply Gem Holdings, Inc. to Announce First Quarter 2017 Results |
| 04/03/2017 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
|